Palmitoylation-dependent estrogen receptor α membrane localization: Regulation by 17β-estradiol

Molecular Biology of the Cell

Volumn 16, Issue 1, 2005, Pages 231-237

  Acconcia, Filippo ^a   Ascenzi, Paolo ^a,b   Bocedi, Alessio ^b,c   Spisni, Enzo ^d   Tomasi, Vittorio ^d   Trentalance, Anna ^a   Visca, Paolo ^a,b   Marino, Maria ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; PROTEIN KINASE B;

ARTICLE; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; HELA CELL; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PALMITOYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; CAVEOLIN 1; CAVEOLINS; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUCIFERASES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; PALMITIC ACID; PALMITIC ACIDS; PHOSPHORYLATION; PLASMIDS; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 11144332004     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E04-07-0547     Document Type: Article

References (47)

1. Acconcia, F., Ascenzi, P., Fabozzi, G., Visca, P., and Marino, M. (2004b). S-Palmitoylation modulates human estrogen receptor-α functions. Biochem. Biophys. Res. Commun. 316, 878-883.
2. Acconcia, F., Totta, P., Ogawa, S., Cardillo, I., Inoue, S., Leone, S., Trentalance, A., Muramatsu, M., and Marino, M. (2004a). Survival versus apoptotic 17β-estradiol effect: role of ERα and ERβ activated non-genomic signalling. J. Cell. Physiol. Published online at www.interscience.wiley.com/DOI10.1002/ 5CP.20219.
3. Arvanitis, D. N., Wang, H., Bagshaw, R. D., Callahan, J. W., and Boggs, J. M. (2004). Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes. J. Neurosci. Res. 75, 603-613.
4. Bijlmakers, M. J., and Marsh, M. (2003). The on-off story of protein palmitoylation. Trends Cell Biol. 13, 32-42.
5. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 772, 248-254.
6. Brzozowski, A. M., Pike, A.C.W., Dauter, Z., Hubbard, R. E., Bonn, T., Engstrom, O., Homan, L., Greene, G. F., Gustafsson, J.-Å., and Carlquist, M. (1997) Molecular basis of agonism and antagoism in the oestrogen receptor. Nature 389, 753-758.
7. Castoria, G., Barone, M. V., Di Domenico, M., Bilancio, A., Ametrano, D., Migliaccio, A., and Auricchio, F. (1999). Non-trascriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18, 2500-2510.
8. Castoria, G., Migliaccio, A., Bilancio, A., Di Domenico, M., de Falco, A., Lombardi, M., Florentino, R., Varricchio, L., Barone, M. V., and Auricchio, F. (2001). PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20, 6050-6059.
9. Chambliss, K. L., and Shaul, P. W. (2002). Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae. Steroids 67, 413-419.
10. Chambliss, K. L., Yuhanna, I. S., Anderson, R. G., Mendelsohn, M. E., and Shaul, P. W. (2002). ERβ has nongenomic action in caveolae. Mol. Endocrinol. 16, 938-946.
11. Coleman, K. M., and Smith, C. L. (2001). Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front. Biosci. 6, D1379-D1391.
12. Dan, P., Cheung, J.C., Scriven, D. R., and Moore, E. D. (2003). Epitope-dependent localization of estrogen receptor-α, but not -β, in en face arterial endothelium. Am. J. Physiol. 284, H1295-H1306.
13. Deecher, D. C., Swiggard, P., Frail, D. E., and O'Connor, L. T. (2003). Characterization of a membrane-associated estrogen receptor in a rat hypothalamic cell line (D12). Endocrine 22, 211-223.
14. Fernando, R. I., and Wimalasena, J. (2004). Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras dependent non-genomic pathways requiring signaling through ERK and AKT. Mol. Biol. Cell 15, 3266-3284.
15. Han, J. M., Kim, Y., Lee, J. S., Lee, C. S., Lee, B. D., Ohba, M., Kuroki, T., Suh, P.-G., and Ryu, S. H. (2002). Localization of phospholipase D1 to caveolin-enriched membrane via palmitoylation: implications for epidermal growth factor signalling. Mol. Biol. Cell 13, 3976-3988.
16. Hegy, G. B., Shackleton, C. H., Carlquist, M., Bonn, T., Engstrom, O., Sjoholm, P., and Witkowska, H. E. (1996). Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid. Steroids 61, 367-373.
17. 1 promoter. Oncogene 9, 1295-1304.
18. Jakacka, M., Ito, M., Martinson, F., Ishikawa, T., Lee, E. J., and Jameson, J. L. (2002). An estrogen receptor ERα deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol. Endocrinol. 16, 2188-2201.
19. Katzenellenbogen, B. S., Bhardwaj, B., Fang, H., Ince, B. A., Pakdel, F., Reese, J. C., Schodin, D. and Wrenn, C. K. (1993) Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems. J. Steroid. Biochem. Mol. Biol. 47, 39-48.
20. Kelly, M. J., and Levin, E. R. (2001). Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12, 152-156.
21. Kousteni, S., et al. (2001). Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104, 719-790.
22. Levin, E. R. (2001). Cell localization, physiology, and nongenomic actions of estrogen receptors. J. Appl. Physiol. 91, 1860-1867.
23. Li, L., Haynes, M. P., and Bender, J. R. (2003). Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc. Natl. Acad. Sci. USA 100, 4807-4812.
24. Lobenhofer, E. K., Huper, G., Iglehart, J. D., and Marks, J. R. (2000). Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ. 11, 99-110.
25. Mardones, G., and Gonzalez, A. (2003). Selective plasma membrane permeabilization by freeze-thawing and immunofluorescence epitope access to determine the topology of intracellular membrane proteins. J. Immunol. Methods 275, 169-177.
26. 3-PKC-α signal transduction pathway in HEPG2 cells. Biochem. Biophys. Res. Commun. 245, 254-258.
27. Marino, M., Distefano, E., Pallottini, V., Caporali, S., Ceracchi, G., and Trentalance, A. (2001a). β-Estradiol stimulation of DNA synthesis requires different PKC isoforms in HepG2 and MCF7 cells. J. Cell Physiol. 188, 170-177.
28. 3 mediate the estrogen receptor activity expressed in human cells. Mol. Cell. Endocrinol. 182, 19-26.
29. 1 gene transcription in HepG2 cells. Mol. Biol. Cell 13, 3720-3729.
30. Marino, M., Acconcia, F., and Trentalance, A. (2003). Biphasic estradiol-induced AKT-phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol. Biol. Cell 14, 2583-2591.
31. Migliaccio, A., Castoria, G., Di Domenico, M., de Falco, A., Bilancio, A., and Auricchio, F. (2002). Src is an initial target of sex steroid hormone action. Ann. N.Y. Acad. Sci. 963, 185-190.
32. Neff, S., Sadowski, C., and Miksicek, R. J. (1994). Mutational analysis of cysteine residues within the hormone-binding domain of the human estrogen receptor identifies mutants that are defective in both DNA-binding and subcellular distribution. Mol. Endocrinol. 8, 1215-1223.
33. Norfleet, A. M., Thomas, M. L., Gametchu, B., and Watson, C. S. (1999). Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140, 3805-3814.
34. Pappas, T. C., Gametchu, B., and Watson, C. S. (1995). Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 9, 404-410.
35. Razandi, M., Pedram, A., Greene, G. L., and Levin, E. R. (1999). Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol. Endocrinol. 13, 307-319.
36. Razandi, M., Pedram, A., and Levin, E. R. (2000). Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol. Endocrinol. 14, 1434-1447.
37. Razandi, M., Oh, P., Pedram, A., Schnitzer, J., and Levin, E. R. (2002). ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol. Endocrinol. 16, 100-115.
38. Razandi, M., Alton, G., Pedram, A., Ghonshani, S., Webb, P., and Levin, E. R. (2003). Identification of a structural determinant necessary for the localization and function of estrogen receptor α at the plasma membrane. Mol. Cell. Biol. 23, 1633-1646.
39. Reid, G., Hubner, M. R., Metivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J., and Cannon, F. (2003). Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 695-707.
40. Resh, M. D. (1999). Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451, 1-16.
41. Ropero, A. B., Soria, B., and Nadal, A. (2002). A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol. Endocrinol. 16, 497-505.
42. Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., and Liao, J. K. (2000). Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407, 538-541.
43. Song, R. X., McPherson, R. A., Adam, L., Bao, Y., Shupnik, M., Kumar, R., and Santen, R. J. (2002). Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol. Endocrinol. 16, 116-127.
44. Song, R. X., Barnes, C. J., Zhang, Z., Bao, Y., Kumar, R., and Santen, R. J. (2004). The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane. Proc. Natl. Acad. Sci. USA 101, 2076-2081.
45. Toran-Allerand, C. D., Guan, X., MacLusky, N. J., Horvath, T. L., Diano, S., Singh, M., Connolly, E. S., Jr., Nethrapalli, I. S., and Tinnikov, A. A. (2002). ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 22, 8391-8401.
46. Varner, A. S., Ducker, C. E., Xia, Z., Zhuang, Y., De Vos, M. L., and Smith, C. D. (2003). Characterization of human palmitoyl-acyl transferase activity using peptides that mimic distinct palmitoylation motifs. Biochem. J. 373, 91-99.
47. Wise, P. M., Dubal, D. B., Wilson, M. E., Rau, S. W., and Bottner, M. (2001). Neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology 142, 969-973.